Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Decrease in Short Interest

Alpha Teknova, Inc. (NASDAQ:TKNO) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 82,600 shares, a decline of 41.8% from the June 30th total of 142,000 shares. Based on an average trading volume of 458,400 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the company’s shares are sold short.

Insider Buying and Selling

In other news, major shareholder Telegraph Hill Partners Iv, L. purchased 12,096,773 shares of the stock in a transaction on Friday, July 12th. The stock was purchased at an average price of $1.24 per share, for a total transaction of $14,999,998.52. Following the acquisition, the insider now owns 11,126,929 shares in the company, valued at $13,797,391.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CEO Stephen Gunstream acquired 80,645 shares of the stock in a transaction dated Friday, July 12th. The stock was bought at an average price of $1.24 per share, for a total transaction of $99,999.80. Following the purchase, the chief executive officer now directly owns 243,497 shares of the company’s stock, valued at approximately $301,936.28. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Telegraph Hill Partners Iv, L. purchased 12,096,773 shares of Alpha Teknova stock in a transaction on Friday, July 12th. The stock was bought at an average price of $1.24 per share, with a total value of $14,999,998.52. Following the completion of the acquisition, the insider now directly owns 11,126,929 shares of the company’s stock, valued at approximately $13,797,391.96. The disclosure for this purchase can be found here. Insiders have purchased a total of 12,217,740 shares of company stock valued at $15,149,998 over the last ninety days. 15.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Alpha Teknova

Several large investors have recently bought and sold shares of TKNO. Fielder Capital Group LLC purchased a new stake in shares of Alpha Teknova in the fourth quarter valued at about $156,000. Conestoga Capital Advisors LLC grew its stake in Alpha Teknova by 4.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after purchasing an additional 9,800 shares during the period. State Board of Administration of Florida Retirement System bought a new stake in shares of Alpha Teknova during the 1st quarter worth $35,000. FourWorld Capital Management LLC purchased a new position in shares of Alpha Teknova in the 1st quarter worth about $135,000. Finally, Redmile Group LLC grew its position in Alpha Teknova by 6.5% during the first quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock valued at $434,000 after buying an additional 10,448 shares during the period. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Trading Up 14.9 %

NASDAQ TKNO opened at $4.08 on Friday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.92 and a current ratio of 5.52. Alpha Teknova has a 52 week low of $1.15 and a 52 week high of $4.27. The business has a 50 day moving average price of $1.73 and a 200-day moving average price of $2.35.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings results on Monday, May 13th. The company reported ($0.20) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.04. Alpha Teknova had a negative net margin of 97.85% and a negative return on equity of 38.24%. The business had revenue of $9.29 million during the quarter, compared to analyst estimates of $7.80 million. During the same quarter in the previous year, the business posted ($0.31) EPS. On average, analysts predict that Alpha Teknova will post -0.65 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Stephens restated an “overweight” rating and issued a $5.00 target price on shares of Alpha Teknova in a research note on Wednesday, July 10th.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.